Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
AMNEAL PHARMACEUTICALS, INC.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Share | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Form | Carry Forward File Number | Carry Forward Initial Effective Date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||
Fees to Be Paid | Equity | Class A Common Stock, par value $0.01 per share | Rule 457(c) | 171,227,752(1) | $2.08(2) | $356,153,724.16 | 0.00011020 | $39,248.14 | ||||||||||||||||
Fees Previously Paid | — | — | — | — | — | — | — | — | ||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||
Carry Forward Securities | — | — | — | — | — | — | — | — | ||||||||||||||||
Total Offering Amounts | $356,153,724.16 | $39,248.14 | ||||||||||||||||||||||
Total Fees Previously Paid | $0 | |||||||||||||||||||||||
Total Fee Offsets | $0 | |||||||||||||||||||||||
Net Fee Due | $39,248.14 |
(1) | Pursuant to Rule 416 under the Securities Act, the Class A common stock being registered hereunder include such indeterminate number of shares of Class A common stock as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions. |
(2) | Pursuant to Rule 457(c) under the Securities Act, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share is $2.08, which is the average of the high and low prices of the Class A common stock on March 1, 2023 on the New York Stock Exchange. |